http://au.news.yahoo.com/thewest/business/a/-/national/9921932/atlas-takes-20pc-stake-in-centaurus/BZL may be the next target.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%